WebMar 20, 2024 · Breath Therapeutics Announces Presentations at Upcoming Scientific Conferences The issuer is solely responsible for the content of this announcem... WebBreath Therapeutics GmbH, a Zambon Group Company Mai 2024–Heute2 Jahre 5 Monate München, Bayern, Deutschland • Management of clinical trial materials for the BOSTON studies. • Oversight of...
Breath Therapeutics Announces Presentations at Upcoming …
WebFeb 20, 2024 · In July 2024, Breath Therapeutics was acquired by Zambon S.p.A, a multinational pharmaceutical company that focuses on innovation and development with … WebFeb 20, 2024 · February 20, 2024 – Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s … brave greed
Breath Therapeutics Gimv
WebMar 26, 2024 · Breath Therapeutics has initiated a Phase III BOSTON clinical trials to evaluate the efficacy and safety of its drug candidate Liposomal Cyclosporine A for Inhalation (L-CsA-i) for the treatment of Bronchiolitis Obliterans Syndrome (BOS). admin BOS is caused by T-cell mediated inflammation that leads to blockage of bronchioles. … WebJul 25, 2024 · About Breath Therapeutics. Founded in 2016, Breath Therapeutics is a private, venture-backed clinical stage biopharmaceutical company specializing in advanced inhaled therapeutics for severe ... WebFeb 20, 2024 · February 20, 2024 – Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives, and Breath Therapeutics, a Zambon company, specializing in advanced inhaled therapeutics for severe respiratory diseases, announced today the … brave gordon